Skip to main content
. Author manuscript; available in PMC: 2020 Jun 4.
Published in final edited form as: Prenat Diagn. 2019 Aug 5;39(9):679–692. doi: 10.1002/pd.5536

TABLE 1.

Drugs shown to influence renal development

Drug Effect of Maternal Treatment During Pregnancy on Fetal Kidney Development Effect of Maternal Treatment While Breastfeeding on Neonatal Kidney Development
Aminoglycosides Tubular alterations, low nephron count Tubular damage, low nephron count
Cyclosporin A Prostaglandin synthetase inhibitors Low nephron count, tubular alterations Glomerular and tubular injury
ACE Inhibitors (ACEIs) Angiotensin Receptor Blocker (ARB) Renal insufficiency Atrophy of renal papilla, tubular alterations, low nephron count
Dexamethasone Altered tubular transporters, low nephron count No effect
Furosemide Renal concentrating defect No effect
Anti-epileptic drugs Increased likelihood of congenital malformations (MCDK)* No effect
Mycophenolate Mofetil Renal agenesis, ectopia No effect
Adriamycin Bladder agenesis, hydronephrosis No effect
Cyclophosphamide Hydronephrosis No effect

Note. This table has been adapted from Schreuder, 2011.6